We report a case of a 15-month-old Japanese girl with Kawasaki disease (KD) associated with bacteremia caused by Streptococcus pneumoniae (S. pneumoniae) 12F (a nonvaccine serotype). The patient had completed the pneumococcal 13valent conjugate vaccination according to the immunization schedule for children in Japan. She presented at the emergency department of our hospital with fever for 3 days and all other KD symptoms and was admitted. Despite the detection of S. pneumoniae 12F in the blood culture on admission, initial treatment for KD with 2 g/kg of intravenous immunoglobulin and 30 mg/kg/day of oral aspirin without antibiotic administration improved both KD symptoms and bacteremia. The patient did not develop coronary aneurysm. Even though there were no reports of KD with bacteremia caused by S. pneumoniae (except in our case), the presence of bacteremia may not affect the treatment response or coronary artery outcome if KD is appropriately treated.
negative. Chest X-ray and electrocardiogram findings were normal. Ultrasonography showed absence of coronary artery aneurysm.
Two days after admission (4 days after fever onset), 2 g/kg of intravenous immunoglobulin (IVIg) and 30 mg/kg/day of oral aspirin were administered. One of the two blood cultures obtained on admission showed Gram-positive cocci that were suggestive of a Staphylococcus epidermidis contamination. Hence, additional blood cultures were performed before starting antibiotic treatment. Three days after admission (5 days after fever onset), the patient was afebrile, indicating that the treatment for KD was effective. However, penicillinsusceptible S. pneumoniae was finally detected from the blood culture sample obtained on admission. S. pneumoniae was also detected from retropharyngeal culture, even though the patient did not have respiratory symptoms. Five days after admission (7 days after fever onset), she had no fever, and the blood culture on day 2 after admission showed negative results. Antibiotic treatment with oral amoxicillin for 10 days was started to prevent recurrent bacteremia, and the patient did not develop any coronary artery aneurysm. The S. pneumoniae 12F serotype was isolated from the blood.
Discussion
KD is an acute systemic vasculitis of unknown etiology that predominantly affects children aged < 5 years [1] . The clinical presentation includes prolonged fever, cervical lymphadenopathy, oral mucosa changes, polymorphous skin rash, bilateral nonpurulent conjunctival injection, and peripheral changes. Although the acute disease is self-limited, coronary artery aneurysms develop in approximately 25% of cases [2] . Reports on KD with viral and bacterial infections exist, but cases associated only with bacteremia are scarce. Our patient had KD with bacteremia caused by S. pneumoniae 12F, a nonvaccine serotype. Interestingly, the initial KD treatment without antibiotic administration improved both KD symptoms and bacteremia, and the patient did not develop coronary aneurysm.
It is known that Staphylococcus aureus and Streptococcus pyogenes are related to the onset of KD due to super antigen [3] . In our patient, it is unlikely that super antigen is associated with KD symptoms because not those two bacteria but S. pneumoniae was isolated. Concomitant bacterial infections can trigger an inflammatory response at the molecular level. IL-1 signaling was shown to be an essential role in the development of KD [4] , and genetic polymorphism in inositol-triphosphate 3kinase C is associated with increased IL-1β cytokine level [5] , while these were not evaluated in our patient. To the best of our knowledge, only eight patients with KD with bacteremia have been reported, as shown in Table 1 [6] [7] [8] [9] [10] [11] . Patients' age ranged from 6 months to 5 years. Including our patient, four patients were male, and three were female, whereas the sex of one patient was unknown. Klebsiella was isolated in two patients, and Staphylococcus aureus in two. Escherichia coli, Streptococcus sanguis and Streptococcus pyogenes, and Clostridium baratii were each isolated in one patient. S. pneumoniae was detected only in our patient. Six patients received antibiotic therapy. Two patients were treated only with aspirin for KD (1980s). Five patients, including ours, were treated with aspirin and IVIg. The patient with Clostridium baratii bacteremia did not receive any specific treatment for bacteremia or KD. Coronary artery aneurysm is a serious KD sequela, but in all reported cases, patients did not develop coronary artery aneurysm, similar to our patient. These findings are consistent with those in a report by Benseler et al., who found that the spectrum of infections at KD diagnosis is broad and does not affect the patients' response to treatment or coronary artery outcomes and that the KD course is similar to that of patients without infection [10] .
Our patient had pneumococcal bacteremia, although she had completed PCV13 vaccinations, which provide coverage against serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F. However, the S. pneumoniae 12F isolated from our patient was a nonvaccine serotype, and this may explain the lack of protection against bacteremia. It is unlikely that KD itself induced bacteremia, but whether KD in our patient was triggered by pneumococcal bacteremia or both conditions were unrelated is unclear. If antibiotic treatment alone KD Kawasaki disease, IVIg Intravenous immunoglobulin, CAL Coronary artery aneurysm, ND Not described improves both KD symptoms and bacteremia, then, bacteremia can be surmised to have induced symptoms mimicking KD. If KD symptoms develop despite antibiotic treatment, then, bacteremia is likely to have induced the KD. However, antibiotic treatment alone was ineffective in our patient, and our standard initial KD treatment without antibiotic administration improved both her KD symptoms and bacteremia. This suggests that pneumococcal infection was associated with KD symptoms. However, we cannot rule out the possibility that both KD and bacteremia separately developed coincidentally in our patient. Children with occult pneumococcal bacteremia have transient infection and recover even without antibiotic therapy [12, 13] , and anti-S. pneumoniae antibody titers are low in IVIg preparations [14] . Therefore, we encountered a patient with KD associated with bacteremia caused by S. pneumoniae 12F, a nonvaccine serotype. The initial KD treatment without antibiotic administration improved both KD symptoms and bacteremia, and the patient did not develop coronary aneurysm. Combined with previous reports, our experience suggests that the presence of bacteremia does not affect the treatment response or the coronary artery outcome, when KD is treated appropriately.
